GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Surmodics Inc.
Surmodics develops coatings for medical devices and its own therapeutic products. Its stock price reflects its dual business model: stable revenue from coatings and riskier, but potentially higher, revenue from its own developments.
Share prices of companies in the market segment - Therapeutic medical equipment
Surmodics develops and licenses technologies for enhancing the surfaces of medical devices and also manufactures its own devices for vascular surgery. We classify it as "Therapeutic Medical Equipment." The chart below shows how this innovative sector is faring.
Broad Market Index - GURU.Markets
Surmodics develops and licenses coating technologies for medical devices and manufactures its own devices for the treatment of vascular diseases. As a significant player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Surmodics' performance.
Change in the price of a company, segment, and market as a whole per day
SRDX - Daily change in the company's share price Surmodics Inc.
Surmodics, a medical coatings company, has volatility measured by change_co. It reflects its sensitivity to clinical trial results and partnerships. This metric is important for analyzing the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Surmodics, Inc. is a medical technology company. This chart shows average daily volatility. Comparing it to SRDX, which focuses on medical device coatings and proprietary product development, helps understand its unique risk profile.
Daily change in the price of a broad market stock, index - GURU.Markets
Surmodics is a manufacturer of medical devices and coatings. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how Surmodics shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Surmodics Inc.
Surmodics, Inc.'s year-over-year performance tells the story of its transition from a supplier of medical device coatings to a manufacturer of its own innovative devices. The 12-month market capitalization reflects progress in clinical trials and commercialization of its drug-eluting balloon catheters, a key element of its transformation strategy.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Surmodics, Inc. is a manufacturer of medical devices and coatings. Its technology is used to improve the performance of catheters and stents. The chart below shows how its unique niche, partnerships with major companies, and clinical trial results influence its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Surmodics, which produces coatings for medical devices, has a protective profile. Demand for its technologies is stable, driven by medical R&D cycles rather than economic trends. The company's share price reflects its success in partnerships and innovation, making it a non-cyclical growth story.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Surmodics Inc.
The value of Surmodics, a medical technology company, depends on its product cycle. The monthly fluctuations on the chart reflect royalty revenue from its medical device coverage and, more importantly, news about clinical trials and approvals of its own therapeutic devices.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Surmodics develops and licenses coating technologies for medical devices (for example, to make stents more biocompatible) and also manufactures its own devices for vascular surgery. The chart below shows the overall dynamics in the medical device sector, reflecting the importance of innovation in both materials and devices.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Stocks in medical coatings and drug delivery systems can be defensive. The chart below shows general market fluctuations. Does Surmodics demonstrate this stability, or does its status as a technology company make it more volatile?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Surmodics Inc.
Surmodics develops coatings for medical devices and its own therapeutic products. Its weekly stock price is volatile, driven by news of partnerships with major medical device manufacturers and clinical trial results. The chart reflects the risks and successes of innovative medicine.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Surmodics, like the entire innovative medical technology sector, is responding to industry-wide news regarding reimbursement systems and FDA regulatory changes. This chart shows how the company is positioned in the context of these sectoral risks and opportunities common to all innovators.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Surmodics develops coatings for medical devices and its own therapeutic products. It's a combination of a stable business and a risky biotech venture. The chart will show which of these factors has the greater impact on the stock. Do they follow the market, or do development news create their own trends?
Market capitalization of the company, segment and market as a whole
SRDX - Market capitalization of the company Surmodics Inc.
The Surmodics, Inc. chart is a story of innovation in medical devices. Its market cap reflects investors' faith in stent and catheter coating technologies, as well as the development of new therapeutic devices. Fluctuations in the chart reflect the results of clinical trials.
SRDX - Share of the company's market capitalization Surmodics Inc. within the market segment - Therapeutic medical equipment
Surmodics, Inc. captures its market share by developing and licensing coatings for medical devices (such as stents) and manufacturing its own vascular surgery products. Its market capitalization reflects the value of its technologies and product portfolio.
Market capitalization of the market segment - Therapeutic medical equipment
Surmodics develops coatings for medical devices. How big is this niche? The graph below shows the overall market capitalization of the therapeutic device sector. Its steady growth reflects the ongoing advancement of medicine and the need for innovations that make implants safer and more effective.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Surmodics chart reflects the long journey from idea to operating room. The company's market capitalization, which develops coatings for medical devices and its own therapeutic catheters, depends on clinical trial results and regulatory approvals. This chart illustrates the risks and potential in the MedTech sector.
Book value capitalization of the company, segment and market as a whole
SRDX - Book value capitalization of the company Surmodics Inc.
Surmodics' core assets are its laboratories and manufacturing facilities, where innovative coatings for medical devices and vascular treatments are created. The book value reflects the value of these knowledge-intensive tangible assets. The chart below shows how the company has invested in its R&D and manufacturing foundation.
SRDX - Share of the company's book capitalization Surmodics Inc. within the market segment - Therapeutic medical equipment
Surmodics, Inc. improves medical devices, and its strength lies in its specialized laboratories and manufacturing facilities. These cleanroom facilities apply unique coatings to stents and catheters. The chart shows the share of this high-tech medical infrastructure the company controls in its niche.
Market segment balance sheet capitalization - Therapeutic medical equipment
Surmodics develops coatings for medical devices. In a capital-intensive industry, its model is knowledge-intensive and asset-light. The industry's asset chart reflects the value of its factories. Surmodics, however, sells its technology and expertise rather than manufacturing its own devices.
Book value of all companies included in the broad market index - GURU.Markets
Surmodics' assets include laboratories and manufacturing facilities for creating unique coatings for medical devices such as stents and catheters. The chart below shows the growth of the company's resources, which improve the compatibility of implants with the human body.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Surmodics Inc.
Surmodics owns laboratories, but the market values their unique coatings for medical devices. The chart shows how much the market valued their intellectual property and patents above the value of their physical assets.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Surmodics develops coatings for medical devices and its own therapeutic products. Its value lies in its patents and technologies. This chart shows the market premium for its intellectual property and new product potential over the value of its laboratories and equipment.
Market to book capitalization ratio for the market as a whole
Surmodics develops coatings for medical devices and its own therapeutic products. Its valuation is a combination of stable revenue from technology licensing and the success of its own developments. Compared to the average in this chart, the market values both its current business and the potential of its future products, creating a premium to its book value.
Debts of the company, segment and market as a whole
SRDX - Company debts Surmodics Inc.
Surmodics develops and licenses coating technologies for medical devices, as well as its own therapeutic products. This chart shows how the company finances its long-term R&D projects. Capital management is aimed at supporting research that can take years to generate stable royalty or sales revenue.
Market segment debts - Therapeutic medical equipment
Surmodics develops and licenses coatings for medical devices (such as stents) and also manufactures its own vascular surgery devices. This dual business requires investment in both R&D and clinical trials. This chart shows how the company's leverage reflects the balance between these two areas and its path to commercialization of its products.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Surmodics Inc.
Surmodics develops and manufactures medical coatings and devices that require significant investment in research and clinical trials. This chart illustrates the role debt plays in funding innovation. It helps understand the company's reliance on lenders throughout the long journey from product development to market launch and profitability.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Surmodics develops coatings for medical devices and drug delivery technologies. This chart shows the debt burden in the therapeutic medical device sector. It helps understand how companies in this innovative industry finance their long-term research and development, and how Surmodics manages its finances on the path to commercialization.
Debt to book value of all companies in the market
Surmodics develops medical coatings and devices that require long-term R&D investment. This chart illustrates the overall dynamics of debt financing in the market. It helps understand whether the company uses debt to finance clinical trials and product launches, and how this approach compares to its overall investment activity.
P/E of the company, segment and market as a whole
P/E - Surmodics Inc.
Surmodics develops coatings for medical devices (such as stents and catheters) that improve their compatibility with the body, as well as the devices themselves. This chart shows how investors value the company, whose technologies help other manufacturers. This trend depends on the success of products that use Surmodics' coatings.
P/E of the market segment - Therapeutic medical equipment
Surmodics develops and licenses coating technologies for medical devices that improve their compatibility with the body and drug delivery. The company also develops its own therapeutic devices. This chart shows the average rating for the therapeutic device sector, reflecting how the market values innovations that improve the effectiveness of medical devices.
P/E of the market as a whole
Surmodics develops and licenses coating technologies for medical devices and manufactures its own vascular surgery devices. Its valuation is a combination of stable licensing revenues and growth potential from its own products. Overall market sentiment, reflected in this chart, has little impact on its business, which is driven by innovation in the medical device sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Surmodics Inc.
Surmodics, Inc. develops coatings for medical devices (such as stents) and the devices themselves for vascular surgery. This chart reflects investor expectations for the success of its products in the medical industry. The valuation depends on forecasts for the adoption of its technologies by medical device manufacturers and the results of clinical trials of its own devices.
Future (projected) P/E of the market segment - Therapeutic medical equipment
Surmodics develops coatings for medical devices that improve their compatibility with the body, as well as its own therapeutic products. This chart reflects the market's view of its dual business model. Comparing its revenue forecasts to the industry reveals the value investors see in its coating technologies and its proprietary developments.
Future (projected) P/E of the market as a whole
Surmodics develops and manufactures coatings for medical devices, as well as its own therapeutic products. The company operates at the intersection of medicine and technology. Against the backdrop of market cycles reflected in this chart, the medical technology sector demonstrates stability, supported by continued demand for healthcare innovation.
Profit of the company, segment and market as a whole
Company profit Surmodics Inc.
Surmodics, Inc. develops and licenses coating technologies for medical devices and manufactures its own therapeutic products. The company's revenue comes from royalties and direct sales. This chart shows the financial performance of the business, which depends on both customer success and the results of its own clinical trials.
Profit of companies in the market segment - Therapeutic medical equipment
Surmodics develops and licenses technologies to improve medical devices, such as coatings for stents and catheters. The company's business depends on its activity in the MedTech sector and successful R&D. This chart illustrates the overall profitability of the therapeutic device industry, providing insight into the innovation cycle and the level of investment in new medical technologies.
Overall market profit
Surmodics develops and manufactures advanced coatings for medical devices and therapeutic technologies. The company's growth is driven by innovation in the medical device sector and an aging population, which creates continued demand. Surmodics' success contributes to the high-tech and profitable healthcare sector, which is a vital component of a healthy and growing economy.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Surmodics Inc.
Surmodics develops coatings for medical devices (such as stents) and diagnostic components. This graph shows the expected success of its proprietary therapeutic devices, currently in development and commercialization. Transitioning from supplier to end-product manufacturer is key to future profitability.
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Surmodics, Inc. develops coatings for medical devices and technologies for vascular treatments. This chart shows total revenue forecasts for the medical device sector. It helps understand how innovations in minimally invasive surgery and demand for advanced medical technologies impact the company's outlook.
Future (predicted) profit of the market as a whole
This chart illustrates expectations for a company developing medical device coatings. Surmodics' profit forecast depends on successful clinical trials and commercialization of its products, particularly drug-eluting balloons. Regulatory approval and physician acceptance of the technology are critical milestones for growth.
P/S of the company, segment and market as a whole
P/S - Surmodics Inc.
Surmodics generates revenue from sales of its own medical devices and licensing of its coating technologies. This chart shows how investors value this hybrid business model. The multiple reflects expectations of growth in new product sales and stable royalty income, creating a diversified revenue stream.
P/S market segment - Therapeutic medical equipment
Surmodics develops coatings for medical devices and drug delivery technologies, generating revenue from licensing fees and sales. This chart illustrates the average industry valuation of medical device manufacturers. It helps investors understand how highly the market values Surmodics' innovative technologies and their contribution to revenue compared to competitors.
P/S of the market as a whole
Surmodics develops and licenses coating technologies for medical devices and creates its own therapeutic products. Its revenue consists of royalties and sales. This chart, showing the average market revenue estimate, serves as a benchmark for Surmodics. It helps understand how the market views its hybrid business model and scientific potential.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Surmodics Inc.
Surmodics develops coatings for medical devices (such as stents) and diagnostic components. The company's future revenue depends on the success of its own products and partnerships with medical device manufacturers. This chart reflects the market's assessment of its R&D pipeline and the commercial prospects of its technologies in the medical industry.
Future (projected) P/S of the market segment - Therapeutic medical equipment
Surmodics develops and licenses coating technologies for medical devices and manufactures its own therapeutic devices. This chart compares the company's estimated future sales with those of other medical device manufacturers. It reflects investor expectations for its product portfolio and the demand for its technologies from other medical companies.
Future (projected) P/S of the market as a whole
Surmodics develops coatings for medical devices (such as stents) and diagnostic components. Its revenue depends on the success of its clients' products—large medical equipment manufacturers. The company's growth reflects innovative activity across the medical industry, which is part of the long-term trends illustrated by this chart.
Sales of the company, segment and market as a whole
Company sales Surmodics Inc.
Surmodics, Inc. develops and licenses coating technologies for medical devices and manufactures its own products for vascular surgery. This chart shows revenue from two sources: royalties from medical industry giants for the use of its coatings and direct sales of its own devices, reflecting the demand for medical innovation.
Sales of companies in the market segment - Therapeutic medical equipment
Surmodics, Inc. develops and licenses coating technologies for medical devices and creates proprietary therapeutic products that improve treatment outcomes for vascular diseases. This chart shows overall sales in the medical device market, illustrating the demand for innovative solutions that improve the safety and effectiveness of medical interventions.
Overall market sales
Surmodics develops and licenses coatings for medical devices (such as stents) that improve their compatibility with the body, and also develops its own therapeutic products. This overall economic activity affects Surmodics indirectly, through the budgets of medical device manufacturers and their willingness to invest in new technologies and R&D.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Surmodics Inc.
Surmodics develops and licenses coating technologies for medical devices (e.g., stents), and also creates its own therapeutic products. The company's future revenue depends on the success of its R&D and the commercialization of new products. This chart shows analyst expectations regarding demand for innovative medical technologies and clinical trial results.
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Surmodics, Inc. develops and licenses coating technologies for medical devices and manufactures its own therapeutic products. This chart shows projected revenues for the entire medical device sector. It reflects expectations for market growth and the adoption of innovative technologies, which impact both licensing revenues and Surmodics' sales.
Future (projected) sales of the market as a whole
Surmodics develops and manufactures coatings for medical devices and therapeutic drugs. Demand for its products depends on activity in the medical technology sector and the level of R&D funding. This graph, reflecting the state of the economy, influences the investment climate in biotech and the budgets of Surmodics' major partner companies, on which its growth depends.
Marginality of the company, segment and market as a whole
Company marginality Surmodics Inc.
Surmodics develops coatings for medical devices and diagnostic components. The chart demonstrates the company's financial performance in the high-tech sector. Profitability depends on the success of its R&D, licensing agreements with major manufacturers, and demand for its innovative solutions that improve medical equipment.
Market segment marginality - Therapeutic medical equipment
Surmodics develops coatings for medical devices and its own therapeutic products. The company operates at the intersection of chemistry and medicine. This chart shows how effectively Surmodics manages its dual business—technology licensing and proprietary product development—compared to other companies in the medical device sector.
Market marginality as a whole
Surmodics develops and licenses coating technologies for medical devices and also develops its own therapeutic products. The company's profitability depends on the success of its licensing partners and progress in its own clinical development. This total market return chart highlights how Surmodics' innovative technologies can generate high margins in the healthcare sector.
Employees in the company, segment and market as a whole
Number of employees in the company Surmodics Inc.
Surmodics develops innovative coatings for medical devices and its own therapeutic products. This graph shows a team of scientists and engineers working at the intersection of chemistry and medicine. The growth of the team is directly related to progress in clinical trials and product commercialization, which requires expansion of both R&D and manufacturing capacity.
Share of the company's employees Surmodics Inc. within the market segment - Therapeutic medical equipment
This chart shows Surmodics, Inc.'s focus in the medical technology industry. The company's workforce in this sector is focused on developing coatings for medical devices (such as stents and catheters) and its own therapeutic products. This team of scientists and engineers creates technologies that improve the compatibility and effectiveness of medical implants.
Number of employees in the market segment - Therapeutic medical equipment
Surmodics, Inc. develops and manufactures coatings for medical devices (such as stents), as well as its own therapeutic products. The company operates at the intersection of chemistry and medicine. This graph illustrates the science-intensive nature of the medtech sector, where Surmodics creates a demand for chemists and engineers who improve the safety and efficacy of medical devices.
Number of employees in the market as a whole
Surmodics, Inc. develops coatings for medical devices and its own therapeutic products. Its business depends on medical innovations and demographic trends, rather than the economic cycles shown in this chart. The company solves complex medical problems for which demand is stable.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Surmodics Inc. (SRDX)
Surmodics develops and manufactures coatings for medical devices and its own therapeutic products. This chart shows how the market values its scientific potential. A rising metric may indicate that investors are pricing in the value of its patents, technologies, and the development portfolio of its research team, rather than its production capacity.
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Surmodics creates coatings for medical devices and diagnostic components, where science and precision are key to success. The company's market value per employee reflects the value of its intellectual property and R&D. Its exceedance of industry averages demonstrates the high market valuation of its unique technologies and their commercial potential.
Market capitalization per employee (in thousands of dollars) for the overall market
Surmodics, Inc. develops and manufactures coatings for medical devices and its own therapeutic products. This chart shows a high salary per employee, which is typical for the medtech sector. The company's value lies in its patents and technologies, which improve the performance of medical devices, creating high added value.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Surmodics Inc. (SRDX)
Surmodics develops and licenses technologies for medical devices, specifically coatings for stents and catheters (to make them slippery or to release drugs). This graph shows the profitability of the "R&D business." Profit is generated either from patent royalties or from sales of its own devices, and the return on investment per engineer should be high.
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Surmodics specializes in surface treatment technologies for medical devices such as stents and catheters. The company generates revenue through licensing and product development. This chart shows how effectively the R&D and commercialization team converts innovation into profit. It reflects the industry average, serving as a benchmark for assessing how Surmodics competes in the medical technology sector.
Profit per employee (in thousands of dollars) for the market as a whole
Surmodics (SRDX) develops and manufactures medical coatings (e.g., for stents) and diagnostic components. It's a high-tech R&D and B2B business. This metric demonstrates how successfully their innovations are converted into profit. High profit per employee means their patented technologies are in demand by major medical device manufacturers, who pay a premium for them.
Sales to employees of the company, segment and market as a whole
Sales per company employee Surmodics Inc. (SRDX)
Surmodics develops and licenses coatings for medical devices and its own therapeutic products. This chart reflects a dual business model. Revenue per employee is generated from both royalties from tech giants and direct sales of its own innovative devices, creating a diversified income stream.
Sales per employee in the market segment - Therapeutic medical equipment
Surmodics specializes in medical devices and coating technologies, particularly in the vascular field. This chart shows the average revenue per employee in this segment. In the medtech industry, where R&D plays a vital role, this is a measure of productivity. How effectively does their team convert innovation into revenue compared to other medical device manufacturers?
Sales per employee for the market as a whole
Surmodics specializes in coating technologies for medical devices (for example, making catheters more slippery) and develops its own therapeutic devices. It is a B2B R&D company. This chart shows how their team of scientists and engineers generates revenue from licensing their technologies and selling their own innovative medical devices.
Short shares by company, segment and market as a whole
Shares shorted by company Surmodics Inc. (SRDX)
Surmodics develops coatings for medical devices (such as stents) and the devices themselves. This chart reflects investor bets against the company. Bearish sentiment may indicate risks associated with the FDA approval process for key products or intense competition in the medical coatings segment, which is putting pressure on margins.
Shares shorted by market segment - Therapeutic medical equipment
Surmodics specializes in coatings for medical devices (for example, for stents, to improve their adhesion) and develops its own therapeutic devices. This chart shows the overall sentiment in the sector. It reflects investor concerns that hospitals will cut back on medical equipment purchases or that regulators will tighten requirements for the sector.
Shares shorted by the overall market
Surmodics produces medical coatings and devices (such as catheters). Its business depends on R&D budgets for medical equipment and elective surgeries. When this fear indicator rises, investors fear that during a recession, companies will cut R&D and patients will postpone elective procedures, reducing demand for SRDX products.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Surmodics Inc. (SRDX)
Surmodics (SRDX) is a medical device company. They develop coatings for devices (such as stents) and the devices themselves (balloon catheters) to treat vascular diseases. This chart measures hype. It shows "overheated" (above 70) on news of FDA approval of their key product or "oversold" (below 30) amid regulatory delays.
RSI 14 Market Segment - Therapeutic medical equipment
Surmodics (SRDX) is a dual-use company: they develop coatings for medical devices (making them "slippery") and their own devices for vascular treatment. This chart tracks the pulse of the Therapeutic Equipment sector. It helps distinguish SRDX's performance from the overall "overheating" or "overselling" of the entire medtech industry.
RSI 14 for the overall market
Surmodics (SRDX) produces medical devices. This chart shows that its business is "defensive." Demand for its products (catheters, coatings) isn't driven by euphoria or panic—it's driven by the need for surgeries. During times of market panic, investors seek safe havens in companies with non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SRDX (Surmodics Inc.)
Surmodics (SRDX) is a medical technology company with two segments: Medical Devices (developing coatings for catheters and stents) and IVD (diagnostic components). This chart displays the average price target. It shows how analysts estimate royalty revenue and sales of peripheral artery disease devices.
The difference between the consensus estimate and the actual stock price SRDX (Surmodics Inc.)
Surmodics is a medical technology company that does two things: develops coatings for medical devices (making them slippery) and creates its own devices (medication balloons). This chart shows the difference between the market valuation and the analyst consensus forecast. It reveals whether experts believe in their key vascular treatment product.
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Surmodics (SRDX) is a medical device company that does two things: develops its own devices (medication balloons) and sells "coatings" for other companies' devices (to make them slippery). This chart shows general expectations for the therapeutic medical device sector. It reflects whether experts believe the coatings market will grow.
Analysts' consensus forecast for the overall market share price
Surmodics (SRDX) is a medical technology company. They make coatings (for stents and catheters) and develop their own devices (for blood vessels). This chart of overall market sentiment is important. Optimism = the market is willing to finance the R&D of unprofitable medical technology companies. In a recession (pessimism), investors value the stable B2B coating business.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Surmodics Inc.
Surmodics (SRDX) is a dual-use company. The first is medical coatings (they license their gliding catheter coatings). The second, and more important, is their proprietary vascular devices (drug-eluting balloons). This chart represents their R&D bet. It weighs their stable licensing business against their binary bet on the approval and success of their flagship device, SurVeil.
AKIMA Market Segment Index - Therapeutic medical equipment
Surmodics (SRDX) is a high-tech B2B medtech company; the company is a leader in two areas: Medical Coatings (licenses its slick catheter coatings) and Proprietary Device Development (medication balloons). This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does this hybrid (B2B coatings + R&D) model (SRDX) differentiate it from the average competitor?
The AKIM Index for the overall market
Surmodics is a provider of coating technologies for medical devices and a manufacturer of proprietary catheters (thrombectomy). This chart, reflecting the market average, is a backdrop. It helps assess how this business, which combines royalties and direct sales in MedTech, fares against the backdrop of general macroeconomic fluctuations.